2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Breast
3
Conditions
Neoplasms
7
Motor Activity
5
Breast Neoplasms
3
Sedentary Behavior
2
Pancreatic Neoplasms
2
Smoking Cessation
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Obesity-Related Malignant Neoplasm
1
Neoplasm Metastasis
1
Mobility Limitation
1
Leukemia
1
Fatigue
1
Cigarette Smoking
1
Chronic Disease
1
Bone Neoplasms
1
Interventions
Trastuzumab
628
Paclitaxel
577
Cyclophosphamide
555
Docetaxel
485
Capecitabine
401
Letrozole
376
Fulvestrant
327
Doxorubicin
294
Carboplatin
279
Tamoxifen
275
Anastrozole
243
exemestane
228
Radiotherapy
218
Epirubicin
211
Bevacizumab
196
palbociclib
189
pertuzumab
186
Vinorelbine
167
Lapatinib
167
Gemcitabine
166
pembrolizumab
162
Surveys and Questionnaires
138
Exercise
136
Magnetic Resonance Spectroscopy
123
Fluorouracil
119
Blood Specimen Collection
118
eribulin
117
Albumin-Bound Paclitaxel
117
Drug Therapy
111
130-nm albumin-bound paclitaxel
111
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Fitness Trackers
×
Clear all
NCT05634395
2025-08-27
GrannyFit
Institut Curie
Phase NA
Active not recruiting
200 enrolled
NCT05011721
2025-03-13
NeoFit
Institut Curie
Phase NA
Completed
300 enrolled
NCT03635723
2024-04-11
BRACELET
Imperial College London
Unknown
75 enrolled